0000000000033413

AUTHOR

M. J. Lopez

showing 5 related works from this author

β-decay of 35Ca

1999

Abstract The β-decay of the T z =− 5 2 nucleus 35 Ca was studied at the LISE3 spectrometer at GANIL. The 35 Ca decay scheme was deduced from its β-delayed proton emission into the ground and excited states of 34 Ar and from its β-delayed two-proton emission. The 35 Ca half-life was determined to be 25.7±0.2 ms. The measured transition strength function B(GT) is compared to results obtained from large-scale sd-shell model calculations.

PhysicsNuclear and High Energy PhysicsDecay schemeSpectrometer010308 nuclear & particles physics01 natural sciences7. Clean energymedicine.anatomical_structureTransition strengthExcited state0103 physical sciencesmedicineProton emissionAtomic physics010306 general physicsNucleusPhysics Letters B
researchProduct

Erratum to “Beta decay half-lives of neutron rich Ti–Co isotopes around N=40” [Nucl. Phys. A 660 (1999) 3–19]

2000

Abstract The neutron-rich 57−59 Ti, 59−62 V, 61−64 Cr, 63−66 Mn, 65−68 Fe, 67−70 Co have been produced at GANIL via interactions of a 60.4 MeV/u 86 Kr 34+ with a 58 Ni target. They have been separated by the doubly achromatic spectrometer LISE3. Beta-decay half-lives have been determined for all produced nuclei, and subsequent γ -rays have been observed for the most efficiently produced nuclei. The measured half-lives of vanadium and chromium isotopes are compared to QRPA calculations using ground states deformations from the FRDM or ETFSI models. In an astrophysical context, the short half-lives of 58 Ti and 64 Cr indicate that these nuclei are potential r-process progenitors, after β -dec…

Nuclear reactionPhysicsNuclear and High Energy PhysicsIsotopes of chromium010308 nuclear & particles physicsContext (language use)[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]7. Clean energy01 natural sciencesBeta decayIsotopes of vanadium0103 physical sciencesNeutronAtomic physics010306 general physicsIsotopes of cobaltRadioactive decayNuclear Physics A
researchProduct

Beta-decay of light nuclei close to the proton drip-line: 40Ti and 35Ca

1998

The s-decay of40Ti and35Ca have been studied at the LISE3 spectrometer at GANIL. The decay schemes were deduced from the observed s-delayed proton and γ emission of40Ti and35Ca into the ground and first excited states of39Ca and34Ar, respectively. The Gamow-Teller strength functionB(GT) of the40Ti s-decay extracted from the s-decay branching ratios and the precisely measured40Ti half-life, provides for the first time an experimental calibration of the neutrino detection efficiency for the ICARUS solar neutrino detector.

ICARUSPhysicsDecay schemePhysics::Instrumentation and Detectors010308 nuclear & particles physicsSolar neutrino[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]7. Clean energy01 natural sciencesBeta decayNuclear physicsNeutrino detectorExcited state0103 physical sciencesHigh Energy Physics::ExperimentPositron emissionAtomic physicsProton emissionNuclear Experiment010306 general physicsComputingMilieux_MISCELLANEOUS
researchProduct

Beta decay half-lives of neutron rich Ti–Co isotopes around

1999

Abstract The neutron-rich 57 – 59 Ti, 59 – 62 V, 61 – 64 Cr, 63 – 66 Mn, 65 – 68 Fe, 67 – 70 Co have been produced at GANIL via interactions of a 60.4 MeV/u 86 Kr 34+ with a 58 Ni target. They have been separated by the doubly achromatic spectrometer LISE3. Beta-decay half-lives have been determined for all produced nuclei, and subsequent γ -rays have been observed for the most efficiently produced nuclei. The measured half-lives of vanadium and chromium isotopes are compared to QRPA calculations using ground states deformations from the FRDM or ETFSI models. In an astrophysical context, the short half-lives of 58 Ti and 64 Cr indicate that these nuclei are potential r-process progenitors, …

PhysicsNuclear reactionNuclear and High Energy PhysicsIsotopes of chromiumIsotopeIsotopes of vanadiumAnalytical chemistryNeutronContext (language use)Atomic physicsBeta decayRadioactive decayNuclear Physics A
researchProduct

Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DAL…

2014

The aims of this study were to describe the variability in protein binding of teicoplanin in critically ill patients as well as the number of patients achieving therapeutic target concentrations. This report is part of the multinational pharmacokinetic DALI Study. Patients were sampled on a single day, with blood samples taken both at the midpoint and the end of the dosing interval. Total and unbound teicoplanin concentrations were assayed using validated chromatographic methods. The lower therapeutic range of teicoplanin was defined as total trough concentrations from 10 to 20 mg/L and the higher range as 10-30 mg/L. Thirteen critically ill patients were available for analysis. The followi…

Malevalidityvalidation proceInternational CooperationSettore MED/41 - Anestesiologiadrug protein bindingGastroenterologylaw.inventionPlasmaStaphylococcus infectionCritically ill patientsInterquartile rangelaw[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesAntibioticsantibiotic therapyPharmacology (medical)Pharmacology & PharmacyAntibiotics; Critically ill patients; Glycopeptides; Hypoalbuminaemia; ICU; Pharmacokinetics; Adult; Aged; Anti-Bacterial Agents; Chromatography; Critical Illness; Female; Humans; International Cooperation; Male; Middle Aged; Plasma; Protein Binding; Teicoplanin; Young Adult; Drug Monitoring; Microbiology (medical); Infectious Diseases; Pharmacology (medical)Antibiotics; Critically ill patients; Glycopeptides; Hypoalbuminaemia; ICU; Pharmacokinetics; Adult; Aged; Anti-Bacterial Agents; Chromatography; Critical Illness; Female; Humans; International Cooperation; Male; Middle Aged; Plasma; Protein Binding; Teicoplanin; Young Adult; Drug Monitoringclinical articleChromatographymedicine.diagnostic_testdrug dose regimencritical illneTeicoplaninHypoalbuminaemiaMedicine (all)articleGlycopeptidesclinical trialGeneral MedicineMiddle Agedtrough time concentrationdrug protein binding variabilityIntensive care unitGlycopeptides Antibiotics Critically ill patients Pharmacokinetics Hypoalbuminaemia ICU3. Good healthAnti-Bacterial Agentsantiinfective agentdrug distributionInfectious Diseases[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitologypriority journalmulticenter study (topic)Vancomycinblood samplingFemaleCritically ill patientDrug MonitoringHumanmedicine.drugProtein BindingMicrobiology (medical)Adultmedicine.medical_specialtyhigh performance liquid chromatographyarea under the curveCritical Illnessultraviolet spectroscopymid dose concentrationchemistryGlycopeptideMicrobiologyteicoplanin adultenterococcal infectionyoung adult Adultdrug clearanceYoung AdultTherapeutic indexPharmacokineticsInternal medicineAnti-Bacterial AgentmedicineHumanssteady statePharmacokineticsDosingAgedbusiness.industrydrug half lifeAntibioticrecommended drug doseAntibiotics; Critically ill patients; Glycopeptides; Hypoalbuminaemia; ICU; Pharmacokinetics; Adult; Aged; Anti-Bacterial Agents; Chromatography; Critical Illness; Female; Humans; International Cooperation; Male; Middle Aged; Plasma; Protein Binding; Teicoplanin; Young Adult; Drug Monitoring; Microbiology (medical); Infectious Diseases; Pharmacology (medical); Medicine (all)calibrationSurgerymulticenter studyTherapeutic drug monitoringdrug blood levelICU[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacologyfree plasma drug concentrationTeicoplaninbusinessmetabolism
researchProduct